A biotech company running low on cash is shelling out millions of dollars to cut ties with its Boston-area headquarters prematurely.

A biotech company running low on cash is shelling out millions of dollars to cut ties with its Boston-area headquarters prematurely.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
200 Talcott Ave, Watertown, MA
Real Estate